Michael Secora, CFO: Recursion Pharmaceuticals RXRX Sell · Filed 24/06/17

Trade details

Type: Insider sale
Amount: $139,800
Shares · price: 15,000 sh · $9.32 a share
Held after: 1,243,468 sh
Stock: Recursion Pharmaceuticals RXRX
Person: Michael SecoraCFO
Trade date: 24/06/13
Filed: 24/06/17
Days to filing: 4 days

Sold 1.2% of holdings

Share of holding sold: 1.2%

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/05/14~24/07/13

Michael Secora's recent trades

Michael SecoraFormer Officer
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$32.6K
5,000 sh
$32.6K
Filed 25/01/17
Traded 25/01/17
Michael SecoraFormer Officer
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$98.5K
15,000 sh
$98.5K
Filed 25/01/15
Traded 25/01/15
Michael SecoraFormer Officer
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$97.2K
15,000 sh
$97.2K
Filed 25/01/14
Traded 25/01/14
Michael SecoraCFO
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$114.9K
15,000 sh
$114.9K
Filed 24/11/14
Traded 24/11/13
Michael SecoraCFO
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$114.6K
15,000 sh
$114.6K
Filed 24/11/14
Traded 24/11/12

Michael Secora, CFO — sold $139.8K of Recursion Pharmaceuticals RXRX · 1.2% of holdings · 10b5-1 plan | Whalegun